| Item Type | Name |
|
Concept
|
Combined Modality Therapy
|
|
Concept
|
Drug Therapy, Combination
|
|
Concept
|
Genetic Therapy
|
|
Concept
|
Treatment Failure
|
|
Concept
|
Salvage Therapy
|
|
Concept
|
Treatment Outcome
|
|
Concept
|
Neoadjuvant Therapy
|
|
Concept
|
Molecular Targeted Therapy
|
|
Concept
|
Organ Sparing Treatments
|
|
Academic Article
|
Update on transrectal ultrasound-guided needle biopsy of the prostate.
|
|
Academic Article
|
Eosinophilic cystitis presenting as a recurrent symptomatic bladder mass following intravesical mitomycin C therapy.
|
|
Academic Article
|
Health related quality of life in patients treated with radical cystectomy and urinary diversion for urothelial carcinoma of the bladder: development and validation of a new disease specific questionnaire.
|
|
Academic Article
|
Positive influence of robotically assisted laparoscopic prostatectomy on the collaborative-care pathway for open radical prostatectomy.
|
|
Academic Article
|
Erectile function outcome reporting after clinically localized prostate cancer treatment.
|
|
Academic Article
|
Estrogenic side effects of androgen deprivation therapy.
|
|
Academic Article
|
Contemporary open radical cystectomy: analysis of perioperative outcomes.
|
|
Academic Article
|
The von Hippel-Lindau gene: turning discovery into therapy.
|
|
Academic Article
|
Outcomes of patients undergoing radical cystoprostatectomy for bladder cancer with prostatic involvement on final pathology.
|
|
Academic Article
|
Impact of surgeon and hospital volume on outcomes of radical prostatectomy.
|
|
Academic Article
|
The relationship between perioperative blood transfusion and overall mortality in patients undergoing radical cystectomy for bladder cancer.
|
|
Academic Article
|
Tumour size, tumour complexity, and surgical approach are associated with nephrectomy type in small renal cortical tumours treated electively.
|
|
Academic Article
|
Trends in the use of perioperative chemotherapy for localized and locally advanced muscle-invasive bladder cancer: a sign of changing tides.
|
|
Academic Article
|
Impact of complications and hospital-free days on health related quality of life 1 year after radical cystectomy.
|
|
Academic Article
|
Use of intravesical valrubicin in clinical practice for treatment of nonmuscle-invasive bladder cancer, including carcinoma in situ of the bladder.
|
|
Academic Article
|
Oncologic Outcomes after Anterior Exenteration for Muscle Invasive Bladder Cancer in Women.
|
|
Academic Article
|
TPX2 as a prognostic indicator and potential therapeutic target in clear cell renal cell carcinoma.
|
|
Academic Article
|
Concomitant CIS on TURBT does not impact oncological outcomes in patients treated with neoadjuvant or induction chemotherapy followed by radical cystectomy.
|
|
Academic Article
|
Impact of sex on response to neoadjuvant chemotherapy in patients with bladder cancer.
|
|
Academic Article
|
Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer.
|
|
Academic Article
|
Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline PART I.
|
|
Academic Article
|
Management of stage T1 superficial bladder cancer with intravesical bacillus Calmette-Guerin therapy.
|
|
Academic Article
|
Beneficial impact of a clinical care pathway in patients with testicular cancer undergoing retroperitoneal lymph node dissection.
|
|
Academic Article
|
Urethral recurrence in patients following orthotopic urinary diversion.
|
|
Academic Article
|
Androgen and anti-androgen treatment modulates androgen receptor activity and DJ-1 stability.
|
|
Academic Article
|
Toxicity following high-dose salvage radiotherapy after radical prostatectomy.
|
|
Academic Article
|
Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the reporting of surgical outcomes.
|
|
Academic Article
|
Effect of a large prostate gland on open and robotically assisted laparoscopic radical prostatectomy.
|
|
Academic Article
|
National practice patterns for immediate postoperative instillation of chemotherapy in nonmuscle invasive bladder cancer.
|
|
Academic Article
|
Surgical and chemotherapeutic management of regional lymph nodes in bladder cancer.
|
|
Academic Article
|
ICUD-EAU International Consultation on Bladder Cancer 2012: Radical cystectomy and bladder preservation for muscle-invasive urothelial carcinoma of the bladder.
|
|
Academic Article
|
Korean version of the functional assessment of cancer therapy (FACT)-vanderbilt cystectomy index (VCI): translation and linguistic.
|
|
Academic Article
|
Statin use is associated with improved survival in patients undergoing surgery for renal cell carcinoma.
|
|
Academic Article
|
Diagnosis and management of urothelial carcinoma in situ of the lower urinary tract: a systematic review.
|
|
Academic Article
|
The Evolving Biology of Castration-Resistant Prostate Cancer: Review of Recommendations From the Prostate Cancer Clinical Trials Working Group 3.
|
|
Academic Article
|
Advances in the management of castration resistant prostate cancer.
|
|
Academic Article
|
The prognostic value of the neutrophil-to-lymphocyte ratio in patients with muscle-invasive bladder cancer treated with neoadjuvant chemotherapy and radical cystectomy.
|
|
Academic Article
|
Optimizing the role of androgen deprivation therapy in advanced prostate cancer: Challenges beyond the guidelines.
|
|
Academic Article
|
Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline PART II.
|
|
Academic Article
|
Comparative effectiveness of neoadjuvant chemotherapy in bladder and upper urinary tract urothelial carcinoma.
|
|
Academic Article
|
Radical cystectomy for bladder cancer: the case for early intervention.
|
|
Academic Article
|
Non-muscle-invasive bladder cancer: the role of radical cystectomy.
|
|
Academic Article
|
Comparison of length of hospital stay between radical retropubic prostatectomy and robotic assisted laparoscopic prostatectomy.
|
|
Academic Article
|
The evidence-based pathway for peri-operative management of open and robotically assisted laparoscopic radical prostatectomy.
|
|
Academic Article
|
A comparison of the incidence and location of positive surgical margins in robotic assisted laparoscopic radical prostatectomy and open retropubic radical prostatectomy.
|
|
Academic Article
|
Neovesical-urethral anastomotic stricture after orthotopic urinary diversion: presentation and management.
|
|
Academic Article
|
A critical review of clinical practice guidelines for the management of clinically localized prostate cancer.
|
|
Academic Article
|
Comparison of american joint committee on cancer pathological stage T2a versus T2b urothelial carcinoma: analysis of patient outcomes in organ confined bladder cancer.
|
|
Academic Article
|
Comparison of American Joint Committee on Cancer pathologic stage T3a versus T3b urothelial carcinoma: analysis of patient outcomes.
|
|
Academic Article
|
Immediate surgical outcomes for radical prostatectomy in the University HealthSystem Consortium Clinical Data Base: the impact of hospital case volume, hospital size and geographical region on 48,000 patients.
|
|
Academic Article
|
Should pelvic lymph node dissection be performed with radical prostatectomy? No.
|
|
Academic Article
|
Preoperative nutritional status is an important predictor of survival in patients undergoing surgery for renal cell carcinoma.
|
|
Academic Article
|
Spurious elevation of serum PSA after curative treatment for prostate cancer: clinical consequences and the role of heterophilic antibodies.
|
|
Academic Article
|
Salvage robotic assisted laparoscopic radical prostatectomy: a single institution, 5-year experience.
|
|
Academic Article
|
Trends in the utilization of neoadjuvant chemotherapy in muscle-invasive bladder cancer: results from the National Cancer Database.
|
|
Academic Article
|
Prostate cancer: Could sensitive PSA assays expedite salvage radiotherapy?
|
|
Academic Article
|
Biochemical recurrence-free survival after robotic-assisted laparoscopic vs open radical prostatectomy for intermediate- and high-risk prostate cancer.
|
|
Academic Article
|
Robotic Cystectomy with Intracorporeal Urinary Diversion: Review of Current Techniques and Outcomes.
|
|
Academic Article
|
Hormonal therapy for metastatic prostate cancer: issues of timing and total androgen ablation.
|
|
Academic Article
|
Neoadjuvant chemotherapy plus radical cystectomy versus radical cystectomy alone in clinical T2 bladder cancer without hydronephrosis.
|
|
Academic Article
|
Pathological staging and biochemical recurrence after neoadjuvant androgen deprivation therapy in combination with radical prostatectomy in clinically localized prostate cancer: results of a phase II study.
|
|
Academic Article
|
The indications, rationale, and results of neoadjuvant androgen deprivation in the treatment of prostatic cancer: Memorial Sloan-Kettering Cancer Center results.
|
|
Academic Article
|
Evaluating neoadjuvant therapy effectiveness on systemic disease: use of a prostatic-specific membrane reverse transcription polymerase chain reaction.
|
|
Academic Article
|
Complications of contemporary radical nephrectomy: comparison of open vs. laparoscopic approach.
|
|
Academic Article
|
Adjuvant weekly docetaxel for patients with high risk prostate cancer after radical prostatectomy: a multi-institutional pilot study.
|
|
Academic Article
|
Guideline for the management of clinically localized prostate cancer: 2007 update.
|
|
Academic Article
|
Radical nephrectomy surgical outcomes in the University HealthSystem Consortium Data Base: Impact of hospital case volume, hospital size, and geographic location on 40,000 patients.
|
|
Academic Article
|
Preoperative hydronephrosis predicts extravesical and node positive disease in patients undergoing cystectomy for bladder cancer.
|
|
Academic Article
|
Long-term efficacy and tolerability of once-yearly histrelin acetate subcutaneous implant in patients with advanced prostate cancer.
|
|
Academic Article
|
Voiding function in women with orthotopic neobladder urinary diversion.
|
|
Academic Article
|
Locoregional small cell carcinoma of the bladder: clinical characteristics and treatment patterns.
|
|
Academic Article
|
Racial variation in the quality of surgical care for bladder cancer.
|
|
Academic Article
|
Multicenter assessment of neoadjuvant chemotherapy for muscle-invasive bladder cancer.
|
|
Academic Article
|
Short term complications from transurethral resection of bladder tumor.
|
|
Academic Article
|
Salvage Surgery After Renal Mass Ablation.
|
|
Academic Article
|
Nomogram Predicting Bladder Cancer-specific Mortality After Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-invasive Bladder Cancer: Results of an International Consortium.
|
|
Academic Article
|
Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial.
|
|
Academic Article
|
Analysis of microsurgical penile revascularization results by etiology of impotence.
|
|
Academic Article
|
The treated natural history of high risk superficial bladder cancer: 15-year outcome.
|
|
Academic Article
|
Identifying the Optimal Number of Neoadjuvant Chemotherapy Cycles in Patients with Muscle Invasive Bladder Cancer.
|
|
Academic Article
|
Association of age with response to preoperative chemotherapy in patients with muscle-invasive bladder cancer.
|
|
Academic Article
|
Antiadenovirus Antibodies Predict Response Durability to Nadofaragene Firadenovec Therapy in BCG-unresponsive Non-muscle-invasive Bladder Cancer: Secondary Analysis of a Phase 3 Clinical Trial.
|
|
Academic Article
|
Genetic Factors Associated with Prostate Cancer Conversion from Active Surveillance to Treatment.
|